These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 26476418)

  • 1. Extent of lymph node dissection and overall survival in patients with uterine carcinosarcoma, papillary serous and endometrioid adenocarcinoma: A retrospective cohort study.
    Alagkiozidis I; Weedon J; Grossman A; Wang P; Mize B; Wilson K; Shah T; Economos K; Salame G; Abulafia O; Lee YC
    Int J Surg; 2015 Dec; 24(Pt A):9-13. PubMed ID: 26476418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative Survival Outcomes of Uterine Papillary Serous Carcinoma, Clear Cell Carcinoma, Grade 3 Endometrioid Adenocarcinoma, and Carcinosarcoma of Endometrial Cancer in Rajavithi Hospital.
    Prueksaritanond N; Chantape W
    J Med Assoc Thai; 2016 Feb; 99 Suppl 2():S75-83. PubMed ID: 27266220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival impact of cytoreduction to microscopic disease for advanced stage cancer of the uterine corpus: a retrospective cohort study.
    Alagkiozidis I; Grossman A; Tang NZ; Weedon J; Mize B; Salame G; Lee YC; Abulafia O
    Int J Surg; 2015 Feb; 14():61-6. PubMed ID: 25576762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival after pelvic exenteration for uterine malignancy: A National Cancer Data Base study.
    Seagle BL; Dayno M; Strohl AE; Graves S; Nieves-Neira W; Shahabi S
    Gynecol Oncol; 2016 Dec; 143(3):472-478. PubMed ID: 27760707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing the effects of lymphadenectomy and radiation therapy in patients with uterine carcinosarcoma: a SEER analysis.
    Nemani D; Mitra N; Guo M; Lin L
    Gynecol Oncol; 2008 Oct; 111(1):82-8. PubMed ID: 18674808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of histology and surgical approach on survival among women with early-stage, high-grade uterine cancer: An NRG Oncology/Gynecologic Oncology Group ancillary analysis.
    Fader AN; Java J; Tenney M; Ricci S; Gunderson CC; Temkin SM; Spirtos N; Kushnir CL; Pearl ML; Zivanovic O; Tewari KS; O'Malley D; Hartenbach EM; Hamilton CA; Gould NS; Mannel RS; Rodgers W; Walker JL
    Gynecol Oncol; 2016 Dec; 143(3):460-465. PubMed ID: 27743738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prognostic significance of aortic lymph node metastasis in endometrial cancer: Potential implications for selective aortic lymph node assessment.
    Cosgrove CM; Cohn DE; Rhoades J; Felix AS
    Gynecol Oncol; 2019 Jun; 153(3):505-510. PubMed ID: 30935714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphadenectomy in Early-Stage Intermediate-/High-Risk Endometrioid Endometrial Cancer: Clinical Characteristics and Outcomes in an Australian Cohort.
    Farrell R; Dixon SC; Carter J; Webb PM
    Int J Gynecol Cancer; 2017 Sep; 27(7):1379-1386. PubMed ID: 30814240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Chemotherapy and Radiotherapy on Management of Early Stage Clear Cell and Papillary Serous Carcinoma of the Uterus.
    Hong JC; Foote J; Broadwater G; Gaillard S; Havrilesky LJ; Chino JP
    Int J Gynecol Cancer; 2017 May; 27(4):720-729. PubMed ID: 28375927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic factors for disease-free and overall survival of patients with uterine carcinosarcoma.
    Şükür YE; Taşkın S; Varlı B; Ateş C; Güngör M; Ortaç F
    Int J Clin Oncol; 2018 Feb; 23(1):114-120. PubMed ID: 28836024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathological characteristics, treatment and outcomes in uterine carcinosarcoma and grade 3 endometrial cancer patients: a comparative study.
    Zhu J; Wen H; Bi R; Wu X
    J Gynecol Oncol; 2016 Mar; 27(2):e18. PubMed ID: 26463439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimal cytoreductive surgery in patients with advanced uterine carcinosarcoma: A multi-institutional retrospective study from the Japanese gynecologic oncology group.
    Harano K; Hirakawa A; Yunokawa M; Nakamura T; Satoh T; Nishikawa T; Aoki D; Ito K; Ito K; Nakanishi T; Susumu N; Takehara K; Watanabe Y; Watari H; Saito T
    Gynecol Oncol; 2016 Jun; 141(3):447-453. PubMed ID: 27072806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An analysis of current treatment practice in uterine papillary serous and clear cell carcinoma at two high volume cancer centers.
    Vogel TJ; Knickerbocker A; Shah CA; Schiff MA; Isacson C; Garcia RL; Goff BA
    J Gynecol Oncol; 2015 Jan; 26(1):25-31. PubMed ID: 25376917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival advantage associated with multimodal therapy in women with node-positive (stage-IIIC) uterine papillary serous carcinoma: a National Cancer Database study.
    Lin JF; Muñiz K; Sukumvanich P; Gehrig P; Beriwal S; Kelley JL; Edwards RP; Olawaiye AB
    BJOG; 2016 Oct; 123(11):1846-52. PubMed ID: 26537059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uterine papillary serous carcinoma pre-operatively diagnosed as endometrioid carcinoma: Is omentectomy necessary?
    Peled Y; Aviram A; Krissi H; Gershoni A; Sabah G; Levavi H; Eitan R
    Aust N Z J Obstet Gynaecol; 2015 Oct; 55(5):498-502. PubMed ID: 26235227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphadenectomy and Adjuvant Therapy Improve Survival with Uterine Carcinosarcoma: A Large Retrospective Cohort Study.
    Versluis MAC; Pielsticker C; van der Aa MA; de Bruyn M; Hollema H; Nijman HW
    Oncology; 2018; 95(2):100-108. PubMed ID: 29791913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Lymph Node Density With Survival of Patients With Papillary Thyroid Cancer.
    Amit M; Tam S; Boonsripitayanon M; Cabanillas ME; Busaidy NL; Grubbs EG; Lai SY; Gross ND; Sturgis EM; Zafereo ME
    JAMA Otolaryngol Head Neck Surg; 2018 Feb; 144(2):108-114. PubMed ID: 29192312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uterine carcinosarcomas and grade 3 endometrioid cancers: evidence for distinct tumor behavior.
    Bansal N; Herzog TJ; Seshan VE; Schiff PB; Burke WM; Cohen CJ; Wright JD
    Obstet Gynecol; 2008 Jul; 112(1):64-70. PubMed ID: 18591309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival implications of staging lymphadenectomy for non-endometrioid endometrial cancers.
    Venigalla S; Chowdhry AK; Shalowitz DI
    Gynecol Oncol; 2018 Jun; 149(3):531-538. PubMed ID: 29559170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uterine papillary serous carcinoma (UPSC): a single institution review of 129 cases.
    Slomovitz BM; Burke TW; Eifel PJ; Ramondetta LM; Silva EG; Jhingran A; Oh JC; Atkinson EN; Broaddus RR; Gershenson DM; Lu KH
    Gynecol Oncol; 2003 Dec; 91(3):463-9. PubMed ID: 14675663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.